Fin Milder

Fin Milder is professor Biomolecules & Health at the Research Centre Biobased Economy. He focuses on the underlying molecular processes of health and disease.

The core of the professorship Biomolecules and Health lies in developing biological model systems to determine the impact of biomolecules on living systems in vitro (outside a living organism). The focus is on the valorization of biobased raw materials, ingredients, and processes for products that enhance the quality of life and bodily functions. Fin works in close collaboration with other institutes, such as the UMCG. On of his projects aims to find the cause of resistance against lung cancer treatments, which is a collaboration with Stichting Merels Wereld.